We are live on ! Find out more
CPIX icon

Cumberland Pharmaceuticals

45 hedge funds and large institutions have $34.1M invested in Cumberland Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 20 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% more capital invested

Capital invested by funds: $29.4M → $34.1M (+$4.71M)

0% more funds holding

Funds holding: 4545 (0)

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

55% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 20

Holders
45
Holders Change
Holders Change %
0%
% of All Funds
1.31%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
9
Reduced
20
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Group One Trading
51
Group One Trading
Illinois
-$2K -365 Closed

CPIX Hedge Fund Activity: Q4 2013 in Review

45 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q4 2013, worth a combined $34.1M — up 16% from $29.4M a quarter earlier.

Fund positioning in CPIX was balanced in Q4 2013: 6 funds opened new positions, 6 closed out, 9 added to existing stakes and 20 trimmed.

The largest buyer was Ariel Investments, adding an estimated $3.81M. The largest seller was BlackRock Institutional Trust, cutting an estimated $2.36M.

  • 45 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q4 2013, unchanged from Q3 2013.
  • Funds reported $34.1M of Cumberland Pharmaceuticals stock for Q4 2013, up 16% quarter-over-quarter.
  • 6 funds opened new Cumberland Pharmaceuticals positions in Q4 2013 and 6 closed out, a net change of 0 holders.
  • The largest Cumberland Pharmaceuticals buyer in Q4 2013 was Ariel Investments, an estimated $3.81M added.
  • The largest Cumberland Pharmaceuticals seller in Q4 2013 was BlackRock Institutional Trust, an estimated $2.36M sold.

Based on aggregated 13F filings for Q4 2013.